---
title: "Xeris Biopharma Holdings, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0ac3517f-98a5-5bae-ae70-e8209062d136
json: https://whiteintel.dev/api/public/dossier/0ac3517f-98a5-5bae-ae70-e8209062d136
identifier: sec:0001867096
jurisdiction: US
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# Xeris Biopharma Holdings, Inc.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001867096`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/0ac3517f-98a5-5bae-ae70-e8209062d136  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0ac3517f-98a5-5bae-ae70-e8209062d136  

## Ownership & control

### UBO chain (walk to the ultimate owner)

A **33-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Xeris Biopharma Holdings, Inc.**. Human view: https://whiteintel.dev/entity/0ac3517f-98a5-5bae-ae70-e8209062d136 · Structured JSON: https://whiteintel.dev/api/public/dossier/0ac3517f-98a5-5bae-ae70-e8209062d136._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._